Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
HHS
Telemedicine Fraud Catches the Eye of HHS OIG
With the rise in telemedicine around the United States, the federal government is increasingly looking at telehealth-related…
PBM Rebate Rule Effective Date Postponed
Readers may remember the Part D rebate final rule finalized by Health and Human Services (HHS) late last year. After the rule was…
Drug Manufacturers Sue HHS Over 340B Advisory Opinion
Three drug companies have filed separate lawsuits to preserve their ability to restrict offerings of 340B-discounted drugs to…
Price Transparency Rule Given the Green Light by D.C. Court of Appeals
On December 29, 2020, the United States Court of Appeals for the District of Columbia Circuit upheld the Centers for Medicare and…
Trump Administration Makes Final Proposed Rule Push
Two proposed rules from the last few weeks of the Trump administration may be of note to some of our readers. The first addresses…
Final Rule Released on the 340B Dispute Process
In mid-December 2020, the United States Department of Health and Human Services (HHS) finalized the long-awaited rule that sets…
COVID-19 Public Health Emergency Declaration Renewed
On January 7, 2021, United States Department of Health and Human Services (HHS) Secretary Alex Azar renewed the COVID-19 public…
Twenty-Eight States Demand Laws Be Enforced on 340B Drug Pricing
On December 14, 2020, the attorneys general for twenty-eight states sent a letter to United States Health and Human Service…
HHS Announces Creation of False Claims Act Working Group
On December 4, 2020, the United States Department of Health and Human Services (HHS) announced the creation of a False Claims Act…
HHS Issues Policy Statements and RFI on Rulemaking and Transparency
On November 24, 2020, the Department of Health and Human Services (HHS) announced two policy statements and a request for…